Skip to main content
CDC Website

English

Talking about Sexual Health: Getting the Care You Need

If you’re a sexually active person— or even if you’re not right now—you probably have questions about your sexual health. Like, should I be tested for STIs? Which ones? Or what are my options for preventing pregnancy? You also might have questions about your libido and why it’s so low…or so high, and whether that’s normal. Or why sex is painful, or getting an erection is so difficult. It’s not always easy to bring these topics up, and it may not be clear exactly what questions you should be asking about your sexual health. 

No Name-Calling Week Educator Guide

The No Name-Calling Week Coalition created by GLSEN and Simon & Schuster Children’s publishing, consisting of over 40 national partner organizations, organized an actual No Name-Calling Week in schools across the nation. The project seeks to focus national attention on the problem of name-calling in schools, and to provide students and educators with the tools and inspiration to launch an ongoing dialogue about ways to eliminate name-calling in their communities.

TB Alliance Stakeholders Association 2022 Virtual Meeting

Today, TB Alliance held a virtual meeting of its Stakeholders Association and other tuberculosis (TB) and global health stakeholders around the world to highlight the recent rapid communication issued by the World Health Organization (WHO) Global Tuberculosis Programme regarding updated guidelines for treating drug-resistant tuberculosis (DR-TB) and their potential impact on DR-TB therapy.

Fight TB: Know the signs and symptoms

Since January of 2016, we have seen an increase of multidrug-resistance tuberculosis (MDR TB) in Minnesota. The severe increase in these rates is due to an MDR TB outbreak within the Hmong community of the east metro. What is very concerning about this outbreak is that it is not regular TB, but MDR TB. This means some of the typical medicines used to treat TB do not work, and we need to use stronger medications over a long period of time to get rid of the disease.

Think TB

Infographic: Refer clients with symptoms lasting more than 2-3 weeks to a medical provider immediately. Clients with infectious TB disease should not be in group settings.

Treatment of Drug-Resistant Tuberculosis An Official ATS/CDC/ERS/IDSA Clinical Practice Guideline

The American Thoracic Society, U.S. Centers for Disease Control and Prevention, European Respiratory Society, and Infectious Diseases Society of America jointly sponsored this new practice guideline on the treatment of drug-resistant tuberculosis (DR-TB). The document includes recommendations on the treatment of multidrug-resistant TB (MDR-TB) as well as isoniazid-resistant but rifampin-susceptible TB.